Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017, Article ID 1230713, 18 pages
https://doi.org/10.1155/2017/1230713
Review Article

Relationship between Insulin Levels and Nonpsychotic Dementia: A Systematic Review and Meta-Analysis

School of Basic Medical Science, Beijing University of Chinese Medicine, No. 11 North Third Ring Road, Chaoyang, Beijing 100029, China

Correspondence should be addressed to Jia-xu Chen; moc.liamtoh@uxaijnehc

Received 20 August 2017; Accepted 16 October 2017; Published 27 December 2017

Academic Editor: Fushun Wang

Copyright © 2017 Qiu-xia Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. U. Onyike, “Psychiatric aspects of dementia,” CONTINUUM: Lifelong Learning in Neurology, vol. 22, no. 2, pp. 600–614, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Umegaki, T. Kawamura, T. Umemura, and N. Kawano, “Factors associated with cognitive decline in older adults with type 2 diabetes mellitus during a 6-year observation,” Geriatrics & Gerontology International, vol. 15, no. 3, pp. 302–310, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Chen, Y. Y. Xu, R. Wu et al., “Impaired learning and memory in rats induced by a high-fat diet: involvement with the imbalance of nesfatin-1 abundance and copine 6 expression,” Journal of Neuroendocrinology, vol. 29, no. 4, 2017. View at Publisher · View at Google Scholar
  4. A. L. Kauffman, J. M. Ashraf, M. R. Corces-Zimmerman, J. N. Landis, and C. T. Murphy, “Insulin signaling and dietary restriction differentially influence the decline of learning and memory with age,” PLoS Biology, vol. 8, no. 5, article e1000372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. C. Li, G. I. Wand, B. Y. Li, H. Sun, and N. C. Jiang, “The effect of insulin on the spatial learning and memory abilities of the Alzheimer’s disease model rats,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 24, no. 4, pp. 494–498, 2008. View at Google Scholar
  6. J. Q. Wang, J. Yin, Y. F. Song et al., “Brain aging and AD-like pathology in streptozotocin-induced diabetic rats,” Journal of Diabetes Research, vol. 2014, Article ID 796840, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Dorrance, N. Matin, and P. W. Pires, “The effects of obesity on the cerebral vasculature,” Current Vascular Pharmacology, vol. 12, no. 3, pp. 462–472, 2014. View at Publisher · View at Google Scholar
  8. J. M. Burns, R. A. Honea, E. D. Vidoni, L. J. Hutfles, W. M. Brooks, and R. H. Swerdlow, “Insulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and aging,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1822, no. 3, pp. 333–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Dorrance, N. Matin, and P. W. Pires, “The effects of obesity on the cerebral vasculature,” Current Vascular Pharmacology, vol. 12, no. 3, pp. 462–472, 2014. View at Publisher · View at Google Scholar
  10. A. M. Dorrance, N. C. Rupp, and E. F. Nogueira, “Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia,” Hypertension, vol. 47, no. 3, pp. 590–595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Craft, L. D. Baker, T. J. Montine et al., “Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial,” Archives of Neurology, vol. 69, no. 1, pp. 29–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. O. Roberts, Y. E. Geda, D. S. Knopman et al., “Association of duration and severity of diabetes mellitus with mild cognitive impairment,” Archives of Neurology, vol. 65, no. 8, pp. 1066–1073, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Y. Jeon, S. R. Kim, H. J. Kim et al., “Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: a case-control study,” Medicine, vol. 95, no. 47, article e5365, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Kenna, F. Hoeft, R. Kelley et al., “Fasting plasma insulin and the default mode network in women at risk for Alzheimer’s disease,” Neurobiology of Aging, vol. 34, no. 3, pp. 641–649, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Mwamburi and W. Q. Qiu, “Different associations of premorbid intelligence vs. current cognition with BMI, insulin and diabetes in the homebound elderly,” Integrative Molecular Medicine, vol. 3, no. 3, pp. 547–552, 2016. View at Publisher · View at Google Scholar
  16. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Journal of Clinical Epidemiology, vol. 62, no. 10, pp. e1–e34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. L. Ownby, E. Crocco, A. Acevedo, V. John, and D. Loewenstein, “Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis,” Archives of General Psychiatry, vol. 63, no. 5, pp. 530–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Chen, The Level of Risk Factors for Cognitive Impairment in Insulin Resistance and Diabetes Rat Brain, [M.Sc. Thesis], Hebei Medical University, 2009.
  19. Q. H. Fang, Risk Factors of Mild Cognitive Impairment in Type 2 Diabetes, [M.Sc. Thesis], Anhui Medical University, 2014.
  20. D. H. Liu, Resting-State Functional MRI Study on the Cognitive Impairment in Type 2 Diabetes Mellitus, [M.Sc. Thesis], Third Military Medical University, 2015.
  21. J. K. Liu, The Research of mTOR and Tau Phosphorylated Protein in Hippocampus Tissue of Type 2 Diabetes and Alzheimer's Disease Rats, [M.Sc. Thesis], Nanchang University, 2012.
  22. Y. F. Mao, The Function and Mechanism of Intranasal Insulin on Alzheimer’s Disease, Dr. Dissertation, Zhejiang University, 2016.
  23. W. Shen, Resting-State Functional Magnetic Resonance Imaging and Neurocognitive Function in Type 2 Diabetes Mellitus, [M.Sc. Thesis], Southern Medical University, 2014.
  24. Y. Wang, Relationship between Cognitive Dysfunction and Vascular Complications in Patients with Type 2 Diabetes Mellitus, [M.Sc. Thesis], Shandong University, 2015.
  25. H. Xiong, L. Ding, W. JJ et al., “Effect the impact of insulin on learning and memory of Alzheimer-like mice and its mechanism,” Tianjin Medical Journal, vol. 41, no. 04, pp. 337–340, 2013. View at Google Scholar
  26. Y. Y. Xiong, Prevalence and Risk Factors for Dementia in Diabetics: A Community-Based Case-Control Study [M.Sc. Thesis], Fudan University, 2008.
  27. H. Y. Yu, Q. S. Wang, P. Li, and B. X. Yang, “The placebo-controlled study of type 2 diabetes patients with mild cognitive impairment,” Chinese Journal of Gerontology, vol. 21, pp. 4087–4089, 2011. View at Google Scholar
  28. T. R. Bomfim, L. Forny-Germano, L. B. Sathler et al., “An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1339–1353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. D. A. Costello, M. Claret, H. Al-Qassab et al., “Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity,” PLoS One, vol. 7, no. 2, article e31124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Hokama, S. Oka, J. Leon et al., “Altered expression of diabetes-related genes in Alzheimer’s disease brains: the Hisayama study,” Cerebral Cortex, vol. 24, no. 9, pp. 2476–2488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Hoscheidt, E. J. Starks, J. M. Oh et al., “Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer’s disease and reduced memory function in at-risk healthy middle-aged adults,” Journal of Alzheimer's Disease, vol. 52, no. 4, pp. 1373–1383, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Maimaiti, K. L. Anderson, C. DeMoll et al., “Intranasal insulin improves age-related cognitive deficits and reverses electrophysiological correlates of brain aging,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 71, no. 1, pp. 30–39, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. T. M. van Himbergen, A. S. Beiser, M. Ai et al., “Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study,” Archives of Neurology, vol. 69, no. 5, pp. 594–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. W. L. Xu, N. L. Pedersen, L. Keller et al., “HHEX_23 AA genotype exacerbates effect of diabetes on dementia and Alzheimer disease: a population-based longitudinal study,” PLoS Medicine, vol. 12, no. 7, article e1001853, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. X. J. Han, P. Yan, L. Wang, L. Cong, and Y. F. Du, “A preliminary study on the changes of insulin signaling pathway in Alzheimer disease,” in National Symposium on Senile Dementia and Related Diseases, vol. 2013, pp. 74-75, Chinese Pharmacological Society, Nanjing, China, 2013. View at Google Scholar
  36. Y. Z. Rong, Y. J. Xie, X. M. Chen, and B. R. Zhou, “Analysis of the correlation among insulin resistance ApoE gene polymorphism and mild cognitive impairment,” Hebei Medicine, vol. 19, no. 11, pp. 1604–1607, 2013. View at Google Scholar
  37. A. Ernst, A. N. Sharma, K. M. Elased, P. C. Guest, H. Rahmoune, and S. Bahn, “Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders,” Translational Psychiatry, vol. 3, article e263, 2013. View at Google Scholar
  38. A. Jayaraman, D. Lent-Schochet, and C. J. Pike, “Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function,” Journal of Neuroinflammation, vol. 11, p. 162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. S. D. Ostergaard, S. Mukherjee, S. J. Sharp et al., “Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study,” PLoS Medicine, vol. 12, no. 6, article e1001841, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. He, Y. Z. Zhang, and X. F. Zhang, “The relationship of cognitive dysfunction in elderly diabetic patients with insulin resistance and care analysis,” China Modern Doctor, vol. 52, no. 28, pp. 138–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. C. Li, G. L. Wang, B. Y. Li, H. Sun, and N. C. Jiang, “Effects of insulin on spatial learning and memory in AD rats,” Chinese Journal of Applied Physiology, vol. 24, no. 04, pp. 494–498, 2008. View at Google Scholar
  42. Y. Yang, D. L. Ma, Y. P. Wang, T. Jiang, S. H. Hu, and X. F. Yu, “Intranasal insulin treatment ameliorates Alzheimer disease-like changes in hippocampus in a rat model of type 2 diabetes,” Chinese Journal of Pathophysiology, vol. 29, no. 01, pp. 56–61, 2013. View at Google Scholar
  43. T. Kawamura, T. Umemura, and N. Hotta, “Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline?” Journal of Diabetes Investigation, vol. 3, no. 5, pp. 413–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. L. J. Cao, “Relationship between cognitive dysfunction and insulin resistance in elderly patients with diabetes mellitus and nursing care,” Nurses Training, vol. 28, no. 03, pp. 266-267, 2013. View at Google Scholar
  45. J. Dong, “Relationship between cognitive dysfunction and insulin resistance in elderly patients with diabetes mellitus and nursing care,” World Latest Medicine Information, vol. 15, no. 105, pp. 303–306, 2015. View at Google Scholar
  46. M. Li, L. Ma, Y. Fan, Z. Q. Song, and J. Li, “Effect of insulin on patients with type 2 diabetes mellitus complicated with mild cognitive impairment,” Cardiovascular Disease Journal of of integrated Traditional Chinese and Western Medicine, vol. 14, no. 20, pp. 2417–20, 2016. View at Google Scholar
  47. N. Mu, S. C. Xu, Q. Chang, D. P. Rao, J. P. Chen, and C. Ma, “Serum lipids, insulin metabolism and 311 gene polymorphism of paraoxonase-2 in patients with different subtypes of Alzheimer’s disease,” Chinese Journal of Gerontology, vol. 34, pp. 5346–5348, 2014. View at Google Scholar
  48. Z. Shen and Y. Lin, “Significance of fasting serum insulin and C peptide in patients with Alzheimer’s disease,” Chinese Journal of Clinical Healthcare, vol. 15, no. 01, pp. 61-62, 2012. View at Google Scholar
  49. L. Su, Q. W. Zhang, W. Li et al., “Effect of course on cognitive function and related risk factors in elderly patients with type 2 diabetes mellitus,” Chinese Journal of Geriatric Heart BrainVessel Diseases, vol. 17, no. 10, pp. 1071–1075, 2015. View at Google Scholar
  50. L. Y. Tang and W. Tang, “Effect of blood glucose fluctuation on the treatment of senile dementia,” The Word Clinical Medicine, vol. 9, no. 7, pp. 67-68, 2015. View at Google Scholar
  51. Q. Tao, “The risk factors of senile patients with type II diabetes,” Modern Hospital, vol. 15, no. 03, pp. 152-153, 2015. View at Google Scholar
  52. Q. H. Zhang and Y. F. Du, “Study on the relationship between cognitive impairment and serum levels of TNF-α and IL-6 in middle-aged and elderly patients with type 2 diabetes mellitus,” in National Symposium on Senile Dementia and Related Diseases, vol. 2013, pp. 67-68, Nanjing: Chinese Pharmacological Society, Nanjing, China, 2013. View at Google Scholar
  53. M. W. Akhtar, S. Sanz-Blasco, N. Dolatabadi et al., “Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation,” Nature Communications, vol. 7, p. 10242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Barron, E. R. Rosario, R. Elteriefi, and C. J. Pike, “Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer’s disease,” PLoS One, vol. 8, no. 10, article e78554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Devi, M. J. Alldred, S. D. Ginsberg, and M. Ohno, “Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer’s disease,” PLoS One, vol. 7, no. 3, article e32792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. D. Ke, F. Delerue, A. Gladbach, J. Gotz, and L. M. Ittner, “Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer’s disease,” PLoS One, vol. 4, no. 11, article e7917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. J. Ramos-Rodriguez, S. Molina-Gil, O. Ortiz-Barajas et al., “Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models,” PLoS One, vol. 9, no. 2, article e89229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Serbedzija, J. E. Madl, and D. N. Ishii, “Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes,” Brain Research, vol. 1303, pp. 179–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Talbot, H. Y. Wang, H. Kazi et al., “Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1316–1338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Y. Mu, “Comparative analysis of insulin resistance in patients with Alzheimer’s disease and type 2 diabetes mellitus,” in The 4th National Symposium on Dementia and Cognitive Impairment and Senior Speeches, vol. 2015, p. 173, Beijing: Chinese Medical Association, Beijing, China, 2015. View at Google Scholar
  61. C. G. Jolivalt, R. Hurford, C. A. Lee, W. Dumaop, E. Rockenstein, and E. Masliah, “Type 1 diabetes exaggerates features of Alzheimer’s disease in APP transgenic mice,” Experimental Neurology, vol. 223, no. 2, article 19931251, pp. 422–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. F. Mao, Z. Guo, T. Zheng et al., “Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice,” Aging Cell, vol. 15, no. 5, pp. 893–902, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Solas, B. Aisa, M. C. Mugueta, R. J. Del, R. M. Tordera, and M. J. Ramirez, “Interactions between age, stress and insulin on cognition: implications for Alzheimer’s disease,” Neuropsychopharmacology, vol. 35, no. 8, pp. 1664–1673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Chen, P. Y. Shan, A. F. Liu, L. Ma, and X. L. Yu, “Plasma fasting glucose, fasting insulin and insulin degrading enzyme in Alzheimer’s disease,” Journal of Shandong University (Health Sciences), vol. 50, no. 03, pp. 75–78, 2012. View at Google Scholar
  65. R. Y. Huang, J. J. Ren, H. Y. Han, and M. N. Tang, “The correlation between metabolic syndrome and Alzheimer’s disease research,” Journal of Psychiatry, vol. 26, no. 03, pp. 175–177, 2013. View at Google Scholar
  66. G. X. Wang, “Correlation analysis of insulin resistance and cognitive impairment,” China Practical Medicine, vol. 6, no. 26, pp. 38-39, 2011. View at Google Scholar
  67. H. M. Kim, J. M. Seong, and J. Kim, “Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus: interactions between treatment modalities and comorbidities,” Medicine, vol. 95, no. 42, article e5016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. N. L. Rasgon, H. A. Kenna, T. E. Wroolie et al., “Insulin resistance and hippocampal volume in women at risk for Alzheimer’s disease,” Neurobiology of Aging, vol. 32, no. 11, pp. 1942–1948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. E. M. Schrijvers, J. C. Witteman, E. J. Sijbrands, A. Hofman, P. J. Koudstaal, and M. M. Breteler, “Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study,” Neurology, vol. 75, no. 22, pp. 1982–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. S. Tan, A. S. Beiser, C. S. Fox et al., “Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study,” Diabetes Care, vol. 34, no. 8, pp. 1766–1770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. M. K. Townsend, O. I. Okereke, W. Xia, T. Yang, D. J. Selkoe, and F. Grodstein, “Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study,” Alzheimer Disease and Associated Disorders, vol. 26, no. 1, pp. 50–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. M. van Oijen, O. I. Okereke, J. H. Kang et al., “Fasting insulin levels and cognitive decline in older women without diabetes,” Neuroepidemiology, vol. 30, no. 3, pp. 174–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. A. A. Willette, S. C. Johnson, A. C. Birdsill et al., “Insulin resistance predicts brain amyloid deposition in late middle-aged adults,” Alzheimers Dement, vol. 11, no. 5, pp. 504–510, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. T. T. Huang, “Effects of insulin resistance on cognitive impairment in patients with Parkinson’s disease,” Journal of Bethune Medical Science, vol. 13, no. 02, pp. 129-130, 2015. View at Publisher · View at Google Scholar
  75. M. Chen, Relationship of Metabolism Related Factors and Alzheimer’s Disease [M.Sc. Thesis], Shandong University, 2012.
  76. Z. S. Deng, Activity of Cholinesterase and Expression of ChAT, Aβof Brain Tissue in Type-2 Diabetic Rat [M.Sc. Thesis], Shanxi Medical University, 2008.
  77. W. G. Liu, R. H. Liu, L. Li et al., “Study of CSF levels of glucose, true insulin, Aβ40 and Aβ42 in patients with Alzheimer’s disease,” Journal of Brain and Nervous Diseases, vol. 17, no. 06, pp. 434–436, 2009. View at Google Scholar
  78. W. G. Liu, R. Z. Tian, Y. Q. Feng et al., “Level of fasting plasma glucose, true insulin, C-peptide and amyloid Beta-protein in patients with Alzheimer disease,” Chinese Rehabilitation Theory and Practice, vol. 13, no. 07, pp. 645-646, 2007. View at Google Scholar
  79. Y. Q. Ma, Study on the Relationship between PI3K/PKB/mTOR/S6K1 Signaling Pathway and Type 2 Diabetes Mellitus and Alzheimer’s Disease, Dr. Dissertation, Nanchang University, 2013.
  80. L. Zhang, Y. Fang, Y. J. Lian, J. K. Wang, Y. K. Zheng, and Z. Y. Luo, “Study on relationship between the insulin resistant with the concentration of tau protein and β-amyloid protein in cerebrospinal fluid of patients with mild cognitive impairment,” Modern Preventive Medicine, vol. 38, no. 09, pp. 1774-1775, 2011. View at Google Scholar
  81. X. H. Zhao, Y. M. Yang, J. Bao, X. Wang, Y. Y. Zhang, and Q. Zhao, “Clinical study on relationship between metabolic syndrome and mild cognitive impairment,” Journal of Kunming Medical University, vol. 05, pp. 82–86, 2012. View at Google Scholar
  82. E. Grunblatt, J. Bartl, D. I. Iuhos et al., “Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction,” Journal of Molecular Psychiatry, vol. 3, no. 1, p. 6, 2015. View at Publisher · View at Google Scholar
  83. W. J. Katon, E. H. Lin, L. H. Williams et al., “Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study,” Journal of General Internal Medicine, vol. 25, no. 5, pp. 423–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Ma, M. Feng, Y. Qian et al., “Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertension,” Yonsei Medical Journal, vol. 56, no. 1, pp. 89–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. M. D. Sullivan, W. J. Katon, L. C. Lovato et al., “Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial,” JAMA Psychiatry, vol. 70, no. 10, pp. 1041–1047, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. B. Y. Ding, The Incidence and Related Risk Factors of Vascular Cognitive Impairment Not Dementia in Inpatients with Diabetes Mellitus Type 2 and Acute Cerebral Infarction, [M.Sc. Thesis], Dalian Medical University, 2015.
  87. J. Hou, The Study for the Change of CMBs-Related Memory Function and Resting-State Brain Function in T2DM with CMBs, [M.Sc. Thesis], Central South University, 2014.
  88. C. H. Shao, K. Li, and X. B. Cao, “Hypertension and related risk factors of vascular dementia,” Chinese Focus Journal, vol. 27, no. 01, pp. 13–15, 2012. View at Google Scholar
  89. X. Zhang, The Control of Glycated Hemoglobin Level and the Use of Insulin Affect the Cognitive Function in Type2 Diabetes, [M.Sc. Thesis], Third Military Medical University, 2014.
  90. X. Liu, Y. N. Zhang, L. H. Jiang, and W. Li, “Abnormal expression of insulin receptor and insulin-like growth factor I receptor in hippocampus of Alzheimer’s disease,” Chinese Journal of Gerontology, vol. 07, pp. 1191–1194, 2011. View at Google Scholar
  91. Y. Ma, D. Wu, W. Zhang, J. Liu, S. Chen, and B. Hua, “Investigation of PI3K/PKB/mTOR/S6K1 signaling pathway in relationship of type 2 diabetes and Alzheimer’s disease,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 10, pp. 18581–18590, 2015. View at Google Scholar
  92. Z. S. Deng, S. L. Zhang, Y. Zhang, Y. Chen, and X. J. Yang, “The study of expression of β-amyloid of serum and brain tissue in type-2 diabetic rat,” Journal of Practical Medical Techniques, vol. 15, no. 12, pp. 1503–1505, 2008. View at Google Scholar
  93. X. Gao, D. Zhao, H. J. Cui, and F. Y. Li, “Study on expression of Aβ in serum and brain tissues in rats with type 2 diabetes mellitus and its relationship with Alzheimer’s disease,” Hebei Medical Journal, vol. 34, no. 22, pp. 3386-3387, 2012. View at Google Scholar
  94. A. H. Lv, S. K. Zhu, and X. M. Zhang, “Effect of insulin resistance on the expression of Aβ protein in hippocampus of rats and the change of cognitive behavior,” Chinese Journal of Practical Nervous Diseases, vol. 14, no. 21, pp. 40-41, 2011. View at Google Scholar
  95. S. H. Yuan, S. Z. Gao, X. P. Liu et al., “The change of cognition function in insulin resistance rats and its brain tissues with Alzheimer-like disease,” Stroke and Neurological Disorders, vol. 17, no. 03, pp. 139–143, 2010. View at Google Scholar
  96. X. J. Zhang, S. S. Yang, M. X. Zhang, and Y. Yang, “Common pathogenesis of type 2 diabetes and Alzheimer’s disease: a potential mechanism,” Chinese Journal of Pathophysiology, vol. 26, no. 06, pp. 1107–1114, 2010. View at Google Scholar
  97. D. Baumeister, R. Akhtar, S. Ciufolini, C. M. Pariante, and V. Mondelli, “Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α,” Molecular Psychiatry, vol. 21, no. 5, pp. 642–649, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Bowden, J. F. Tierney, A. J. Copas, and S. Burdett, “Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics,” BMC Medical Research Methodology, vol. 11, p. 41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Masi, D. S. Quintana, N. Glozier, A. R. Lloyd, I. B. Hickie, and A. J. Guastella, “Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis,” Molecular Psychiatry, vol. 20, no. 4, pp. 440–446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Langhorne, “Bias in meta-analysis detected by a simple, graphical test. Bias in meta-analysis detected by a simple, graphical test. Prospectively identified trials could be used for comparison with meta-analyses,” BMJ, vol. 316, no. 7129, article 9492689, p. 471, 1998. View at Google Scholar
  101. K. L. Soeken and A. Sripusanapan, “Assessing publication bias in meta-analysis,” Nursing Research, vol. 52, no. 1, pp. 57–60, 2003. View at Google Scholar